唐伟，男，医学博士，教授，博士生导师。
学习经历
1996-2000年 山东大学生命科学学院微生物学专业学习，获理学学士学位；
2000-2003年 山东大学生命科学学院微生物学专业学习，获理学硕士学位；
2007-2011年 山东大学医学院病原生物学专业学习，获医学博士学位。
2008-2010年 纽约大学医学院，联合培养。
工作经历
2003年至今，在山东大学医学院医学微生物学教研室（现基础医学院病原生物学系）工作。
讲授课程
医学微生物学；医学微生物学实验；现代医学微生物学
主要研究方向
肾脏损伤与修复机制
承担课题
国家自然科学基金（面上项目）：慢性肾损伤中肾小管上皮细胞DNA复制应激的可变多聚腺苷酸化新机制及其靶向干预，2025.01-2028.12；
国家自然科学基金（面上项目）：肾脏损伤修复的新机制：Bud31介导的可变剪接重编程，2023.01-2026.12；
国家自然科学基金（面上项目）：ISG20介导的氧化RNA降解在急性肾损伤中的作用与机制，2020.01-2023.12；
国家自然科学基金（面上项目）：p204/IFI16介导的免疫调控在急性肾损伤中的作用与机制，2017.01-2020.12；
国家自然科学基金（青年基金项目）：生长因子Progranulin结合TNFR2的关键氨基酸鉴定与结合模式分析，2012.01-2014.12；
山东省重点研发计划：PGRN调控的巨噬细胞极化在急性肾损伤向慢性肾病进展中的功能，2018.01-2019.12；
山东省自然科学基金：干扰素诱导蛋白p204调控小鼠缺血再灌注肾损伤的研究，2016.11-2019.06；
山东省自然科学基金：雌激素协同的HPV致癌机制中RbAp48的作用研究，2010.11-2013.11。
代表性学术论文
1. Zhao S#, Li R#, Xia Y#, Wang X, Liu Z, Chu Q, He J, Zhang J, Guo Y, Wang Y, Wu J, Zhang Y, Wang Z, Zhang Z, Zeng R, Zhang C, Lv J, Sun J*, Tang W*, Yi F*. Targeting ECM-producing cells with CAR-T therapy alleviates fibrosis in chronic kidney disease. Cell Stem Cell. 2025 Sep 4;32(9):1390-1402.e9.
2. Wu JC#, Wang XJ, Zhu JH, Huang XY, Liu M, Qiao Z, Zhang Y, Sun Y, Wang ZY, Zhan P, Zhang T, Hu HL, Liu H, Tang W*, Yi F*. GPR97 deficiency ameliorates renal interstitial fibrosis in mouse hypertensive nephropathy. Acta Pharmacol Sin. 2023 Jun;44(6):1206-1216.
3. Tang W#, Zhang Y, Cui S, Yi F#. The Growth Factors: Potential Biomarkers and Therapeutic Targets in Kidney Diseases. Kidney Dis (Basel). 2022 Sep 12;8(5):368-380.
4. Liu F#, Wei B#, Xu X, Ma B, Zhang S, Duan J, Kong Y, Yang H, Sang Y, Wang S, Tang W*, Liu C*, Liu H*. Nanocellulose-Reinforced Hydroxyapatite Nanobelt Membrane as a Stem Cell Multi-Lineage Differentiation Platform for Biomimetic Construction of Bioactive 3D Osteoid Tissue In Vitro. Adv Healthc Mater. 2021 Apr;10(8):e2001851.
5. Zhou D#, Zhou M#, Wang Z, Fu Y, Jia M, Wang X, Liu M, Zhang Y, Sun Y, Zhou Y, Lu Y, Tang W*, Yi F*. Progranulin alleviates podocyte injury via regulating CAMKK/AMPK-mediated autophagy under diabetic conditions. J Mol Med (Berl). 2019 Nov;97(11):1507-1520.
6. Zhou D#, Zhou M, Wang Z, Fu Y, Jia M, Wang X, Liu M, Zhang Y, Sun Y, Lu Y, Tang W*, Yi F*. PGRN acts as a novel regulator of mitochondrial homeostasis by facilitating mitophagy and mitochondrial biogenesis to prevent podocyte injury in diabetic nephropathy. Cell Death Dis. 2019 Jul 8;10(7):524.
7. Baojin Ma#, Feng Liu, Shan Zhang, Jiazhi Duan, Ying Kong, Zhao Li, Dongqi Tang, Wenjuan Wang, Shaohua Ge*, Wei Tang*, Hong Liu*. Two-photon fluorescent polydopamine nanodots for CAR-T cell function verification and tumor cell/tissue detection. J. Mater. Chem. B, 2018, 6, 6459-6467.
8. Li X#, Zuo Z, Chen Q, Li J, Tang W*, Yang P*. Progranulin is highly expressed in patients with chronic periodontitis and protects against experimental periodontitis in rats. J Periodontol. 2018 Dec;89(12):1418-1427.
9. Ma B#, Zhang S, Liu F, Duan J, Wang S, Han J, Sang Y, Yu X, Li D, Tang W*, Ge S*, Liu H*. One-Dimensional Hydroxyapatite Nanostructures with Tunable Length for Efficient Stem Cell Differentiation Regulation. ACS Appl Mater Interfaces. 2017 Oct 4;9(39):33717-33727.
10. Zhou M#, Tang W#, Fu Y, Xu X, Wang Z, Lu Y, Liu F, Yang X, Wei X, Zhang Y, Liu J, Geng X, Zhang C, Wan Q, Li N, Yi F*. Progranulin protects against renal ischemia/reperfusion injury in mice. Kidney Int. 2015 May;87(5):918-29.
11. Feng T#, Zheng L#, Liu F, Xu X, Mao S, Wang X, Liu J, Lu Y, Zhao W, Yu X, Tang W*. Growth factor progranulin promotes tumorigenesis of cervical cancer via PI3K/Akt/mTOR signaling pathway. Oncotarget. 2016 Sep 6;7(36):58381-58395.
12. Yu Y#, Xu X, Liu L, Mao S, Feng T, Lu Y, Cheng Y, Wang H, Zhao W, Tang W*. Progranulin deficiency leads to severe inflammation, lung injury and cell death in a mouse model of endotoxic shock. J Cell Mol Med. 2016 Mar;20(3):506-17.
13. Xu X#, Gou L, Zhou M, Yang F, Zhao Y, Feng T, Shi P, Ghavamian A, Zhao W, Yu Y, Lu Y, Yi F, Liu G*, Tang W*. Progranulin protects against endotoxin-induced acute kidney injury by downregulating renal cell death and inflammatory responses in mice. Int Immunopharmacol. 2016 Sep;38:409- 419.
14. Lu Y#, Zheng L, Zhang W, Feng T, Liu J, Wang X, Yu Y, Qi M, Zhao W, Yu X*, Tang W*. Growth factor progranulin contributes to cervical cancer cell proliferation and transformation in vivo and in vitro. Gynecol Oncol. 2014 Aug;134(2):364-71.
15. Zheng L#, Tang W#, Wei F, Wang H, Liu J, Lu Y, Cheng Y, Bai X, Yu X*, Zhao W*. Radiation-inducible protein RbAp48 contributes to radiosensitivity of cervical cancer cells. Gynecol Oncol. 2013 Sep;130(3):601-8.
16. Tang W#, Lu Y#, Tian QY#, Zhang Y, Guo FJ, Liu GY, Syed NM, Lai Y, Lin EA, Kong L, Su J, Yin F, Ding AH, Zanin-Zhorov A, Dustin ML, Tao J, Craft J, Yin Z, Feng JQ, Abramson SB, Yu XP, Liu CJ*. The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science. 2011 Apr 22;332(6028):478-84.
